New joint consensus initiative on quantifying atherogenic lipoproteins

被引：1
作者：
Stock, Jane K. [1 ]
机构：
[1] European Atherosclerosis Soc, Massans Gata 10,Box 5243, SE-40224 Gothenburg, Sweden
来源：
ATHEROSCLEROSIS | 2018年 / 279卷
关键词：
New joint consensus initiative on quantifying; atherogenic lipoproteins; Biomarker; Non-HDL-C; Apolipoprotein B; NON-HDL CHOLESTEROL; LDL CHOLESTEROL; APOLIPOPROTEIN-B; RISK; PROGRESSION;
D O I：
10.1016/j.atherosclerosis.2018.08.037
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 99
页数：3
相关论文
共 19 条
  • [1] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
    Catapano, Alberico L.
    Graham, Ian
    De Backer, Guy
    Wiklund, Olov
    Chapman, M. John
    Drexel, Heinz
    Hoes, Arno W.
    Jennings, Catriona S.
    Landmesser, Ulf
    Pedersen, Terje R.
    Reiner, Zeljko
    Riccardi, Gabriele
    Taskinen, Marja-Riita
    Tokgozoglu, Lale
    Verschuren, W. M. Monique
    Vlachopoulos, Charalambos
    Wood, David A.
    Luis Zamorano, Jose
    [J]. ATHEROSCLEROSIS, 2016, 253 : 281 - 344
  • [2] BACHORIK PS, 1995, CLIN CHEM, V41, P1414
  • [3] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
    Boekholdt, S. Matthijs
    Arsenault, Benoit J.
    Mora, Samia
    Pedersen, Terje R.
    LaRosa, John C.
    Nestel, Paul J.
    Simes, R. John
    Durrington, Paul
    Hitman, Graham A.
    Welch, K. M. A.
    DeMicco, David A.
    Zwinderman, Aeilko H.
    Clearfield, Michael B.
    Downs, John R.
    Tonkin, Andrew M.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Kastelein, John J. P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12): : 1302 - 1309
  • [4] Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control
    Carey, Vincent J.
    Bishop, Louise
    Laranjo, Nancy
    Harshfield, Benjamin J.
    Kwiat, Carolyn
    Sacks, Frank M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06) : 757 - 763
  • [5] Residual macrovascular risk in 2013: what have we learned?
    Fruchart, Jean-Charles
    Davignon, Jean
    Hermans, Michel P.
    Al-Rubeaan, Khalid
    Amarenco, Pierre
    Assmann, Gerd
    Barter, Philip
    Betteridge, John
    Bruckert, Eric
    Cuevas, Ada
    Farnier, Michel
    Ferrannini, Ele
    Fioretto, Paola
    Genest, Jacques
    Ginsberg, Henry N.
    Gotto, Antonio M., Jr.
    Hu, Dayi
    Kadowaki, Takashi
    Kodama, Tatsuhiko
    Krempf, Michel
    Matsuzawa, Yuji
    Nunez-Cortes, Jesus Millan
    Monfil, Carlos Calvo
    Ogawa, Hisao
    Plutzky, Jorge
    Rader, Daniel J.
    Sadikot, Shaukat
    Santos, Raul D.
    Shlyakhto, Evgeny
    Sritara, Piyamitr
    Sy, Rody
    Tall, Alan
    Tan, Chee Eng
    Tokgozoglu, Lale
    Toth, Peter P.
    Valensi, Paul
    Wanner, Christoph
    Zambon, Alberto
    Zhu, Junren
    Zimmet, Paul
    [J]. CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [6] Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging SubstudyBrief Report
    Hippe, Daniel S.
    Phan, Binh An P.
    Sun, Jie
    Isquith, Daniel A.
    O'Brien, Kevin D.
    Crouse, John R.
    Anderson, Todd
    Huston, John
    Marcovina, Santica M.
    Hatsukami, Thomas S.
    Yuan, Chun
    Zhao, Xue-Qiao
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (03) : 673 - 678
  • [7] Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
    Kamstrup, Pia R.
    Benn, Marianne
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    [J]. CIRCULATION, 2008, 117 (02) : 176 - 184
  • [8] Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
    Langlois, Michel R.
    Chapman, M. John
    Cobbaert, Christa
    Mora, Samia
    Remaley, Alan T.
    Ros, Emilio
    Watts, Gerald F.
    Boren, Jan
    Baum, Hannsjoerg
    Bruckert, Eric
    Catapano, Alberico
    Descamps, Olivier S.
    von Eckardstein, Arnold
    Kamstrup, Pia R.
    Kolovou, Genovefa
    Kronenberg, Florian
    Langsted, Anne
    Pulkki, Kari
    Rifai, Nader
    Sypniewska, Grazyna
    Wiklund, Olov
    Nordestgaard, Borge G.
    [J]. CLINICAL CHEMISTRY, 2018, 64 (07) : 1006 - 1033
  • [9] Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
    Martin, Seth S.
    Blaha, Michael J.
    Elshazly, Mohamed B.
    Brinton, Eliot A.
    Toth, Peter P.
    McEvoy, John W.
    Joshi, Parag H.
    Kulkarni, Krishnaji R.
    Mize, Patrick D.
    Kwiterovich, Peter O.
    DeFilippis, Andrew P.
    Blumenthal, Roger S.
    Jones, Steven R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) : 732 - 739
  • [10] Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
    Miller, W. Greg
    Myers, Gary L.
    Sakurabayashi, Ikunosuke
    Bachmann, Lorin M.
    Caudill, Samuel P.
    Dziekonski, Andrzej
    Edwards, Selvin
    Kimberly, Mary M.
    Korzun, William J.
    Leary, Elizabeth T.
    Nakajima, Katsuyuki
    Nakamura, Masakazu
    Nilsson, Goeran
    Shamburek, Robert D.
    Vetrovec, George W.
    Warnick, G. Russell
    Remaley, Alan T.
    [J]. CLINICAL CHEMISTRY, 2010, 56 (06) : 977 - 986
12